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Abstract  
Objective 
This cohort study examined the impact of cancer on sexual function and intimate relationships in 
adolescents and young adults (AYAs). We also explored factors predicting an increased 
likelihood that cancer had negatively affected these outcomes.   
Methods 
Participants (n=465, ages 15-39) in the Adolescent and Young Adult Health Outcomes and 
Patient Experience (AYA HOPE) study completed two surveys approximately 1 and 2 years post 
cancer diagnosis. We used multivariable logistic regression to determine factors negatively 
affected by perceptions of sexual function at 2 years post-diagnosis. 
Results 
Forty-nine percent of AYAs reported negative effects on sexual function at one year post cancer 
diagnosis and 70% of those persisted in their negative perceptions two years after diagnosis. 
Those reporting a negative impact at two years were more likely to be 25 years or older (OR, 
2.53; 95% CI, 1.44-4.42), currently not raising children (OR, 1.81; 95% CI, 1.06-3.08), 
experiencing fatigue (OR, .99; 95% CI, .975-.998) and more likely to report that their diagnosis 
has had a negative effect on physical appearance (OR, 3.08; 95% CI, 1.97-4.81).  Clinical factors 
and mental health were not significant predictors of negative effects on sexual function. 
Conclusions  
Many AYAs diagnosed with cancer experience a persistent negative impact on sexual life up to 
two years following diagnosis. The findings underscore the need to develop routine protocols to 
assess sexual function in AYAs with cancer and to provide comprehensive management in the 
clinical setting. 
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Background 
Adolescents and young adults (AYAs) who are diagnosed with cancer and undergo treatment risk 
having detrimental effects on their psychosocial maturation, sexual behavior, identity 
development, and intimate relationships [1, 2]. Cancer-related sexual dysfunction is caused by a 
combination of physiological changes induced by cancer and its treatment (surgery, radiation and 
chemotherapy) [3]. Surgery, depending on the amount of tissue or organ removed, and radiation 
can result in changes to nerves and blood vessels in the genital area. Such changes can cause 
erectile dysfunction and problems with ejaculation in men and affect sexual sensitivity (both 
desire and orgasm) in women and men. Chemotherapy may affect hormones that control normal 
sexual function. Changes in hormone levels may result in symptoms of early menopause in 
women including vaginal dryness, shrinking and loss of elasticity [4]. The extent of these 
problems and resultant psychosocial challenges that accompany sexual problems are not well-
understood for this age group. Early treatment complications such as fatigue and nausea may 
hinder intimacy and interest in sexual activity [5]. Late effects can include unfavorable changes in 
self-esteem and body image as well as physical complications and symptoms that may have 
enduring effects on sexual performance [6, 7].  
Addressing sexual problems for cancer survivors involves consideration and management of 
several biological, psychological, interpersonal or social/cultural factors. Bober and Varela have 
presented an integrative biopsychosocial model on cancer-related sexual problems [3]. Biological 
factors proposed to influence sexual problems include hormonal alterations and changes in body 
integrity due to tissue loss that can cause desensitization, pain, and fatigue. Interpersonal factors 
include relationship challenges such as lack of communication and fear of intimacy. Emotions, 
cognitions, and motivation are also, suggested to impact on sexual problems. Social and cultural 
factors, such as religious beliefs, cultural values and social norms, are additionally important to 
consider when understanding and addressing sexual problems. The Bober and Valera model is an 
attempt to integrate multidimensional factors related to sexual problem and identify points for 
possible intervention\. 
Estimated rates of sexual dysfunction among AYA vary by cancer diagnosis, treatment modality, 
time since diagnosis, and the aspect of sexual health being evaluated. Common reported problems 
include pain, lack of desire, orgasm and arousal difficulties [8]. Additionally women may be 
bothered by vaginal dryness, and men may experience erectile and ejaculatory dysfunction [8]. It 
is difficult to determine prevalence of sexual dysfunction among those diagnosed as AYAs (age 
15-39) because available data combine results with younger and older populations [9]. The 
majority of the existing reports are cross-sectional and there is a lack of results from studies that 
have prospectively assessed sexual function among AYAs with cancer. The prevalence of sexual 
problems in AYAs newly diagnosed with cancer has not been established. Importantly, the 
implications of sexual dysfunction after cancer treatment are different for AYAs versus childhood 
cancer survivors [9], as AYAs are more likely to be establishing intimate partnerships and 
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starting families than older adults while simultaneously navigating a diagnosis and treatment. 
However, we know very little about the needs and concerns of individuals diagnosed and treated 
with cancer during adolescence and young adulthood.  
The population-based Adolescent and Young Adult Health Outcomes and Patient Experience 
(AYA HOPE) study in the United States (U.S.) was designed to identify indicators of potential 
health-related problems. Thus, broad domains were assessed with the intention of determining 
high priority areas for future study. The results have shown a strong impact of cancer on health-
related quality of life (HRQOL) one year following diagnosis of cancer [10]. Additionally AYAs 
reported that cancer negatively affected dating, sexual function and plans for having children 
[11]. The current study compared the prevalence of adverse changes in sexual functioning in this 
cohort at one year and two years post-cancer diagnosis. It also explored factors associated with 
negative effects on sexual functioning and intimate relationships two years after diagnosis. 
Methods 
Sample and setting 
The design, methods, and recruitment of the AYA HOPE study have been previously reported 
[12]. Incident cases of AYAs diagnosed with cancer were identified through one of seven 
National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results (SEER) registries 
(Detroit, Seattle/Puget Sound, Los Angeles County, San Francisco/Oakland, Greater California, 
Iowa, and Louisiana) between July 2007 and October 2008. Study approval was obtained by each 
of the registries’ and NCI’s institutional review boards. Eligible participants were 15-39 years old 
at time of their diagnosis, and diagnosed with non-Hodgkin lymphoma, Hodgkin lymphoma, 
acute lymphoblastic leukemia, germ cell tumor, or sarcoma (Ewing’s, osteosarcoma or 
rhabdomyosarcoma). Before data collection the items included in the survey underwent cognitive 
interviewing with patients to establish face validity and capture possible ambiguity or 
inappropriateness with content. All participants completed a first survey a median of 11 (range 6-
14) months post-diagnosis and were re-contacted for a second survey (follow-up), 15-35 months, 
after diagnosis. Of the eligible participants, 525 agreed to participate by completing and returning 
the mailed survey (one survey was lost, resulting in 524 surveys), and 89% of them (N=465) 
responded to both surveys. Informed consent was obtained from all individual participants 
included in the study. Medical records were received on 436 of these participants. 
 
Measures 
The survey included questions about respondents’ demographic characteristics, quality of health 
care, treatment and symptoms, insurance status, information and service needs, the impact of 
cancer on various domains and HRQOL. Additionally, certain socio-demographics (age, 
race/ethnicity, sex, marital status) and clinical characteristics (cancer type, type of treatment, 
cancer stage) were collected from the SEER registries and patient’s medical records. Because the 
cohort included individuals with different cancer diagnoses and associated treatments, we used a 
previously validated methodology to produce a treatment intensity variable based on cancer type, 
stage, and treatment [13, 14]. Additionally, the follow-up survey included questions on whether 
respondents had finished their cancer treatment (“are you currently scheduled to receive future 
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cancer treatment” and date for last cancer treatment). Current marital status was categorized to 
reflect those currently in a committed relationship (married or living as married) versus not in a 
committed relationship (single/divorced/separated). 
 
Sexual function 
One item from the Life Impact Checklist [11, 15] was used to record impact on sexual function. 
Participants were asked to ‘‘indicate what kind of overall impact your cancer has had on sexual 
function/intimate relations”. Response choices were based on a 6-point scale: 0 (does not apply), 
1 (very negative), 2 (somewhat negative), 3 (no impact), 4 (somewhat positive), and 5 (very 
positive).The distribution of this variable was dichotomized into: any negative impact versus 
positive impact/no impact/does not apply. We additionally conducted a sensitivity analysis 
excluding all individuals who responded ‘does not apply’. As the results did not differ when 
excluded from our analysis, we decided to include them in our final modes to increase power. 
 
HRQOL 
HRQOL was measured with the 12-item Short Form Health Survey (SF-12) [16] and the 
Pediatric Quality of Life Inventory (PedsQLTM) [17]. The SF-12 (version 2) produces two 
normed summary measures of physical and mental health reflecting physical functioning, 
physical role limitations, bodily pain, general health, vitality, social functioning, emotional role 
limitations, and mental health; higher scores reflect better health. The SF-12 has demonstrated 
acceptable psychometric properties in adults [18]. The PedsQL was originally designed for 
children and adolescents but there also exists a young adult version (4.0), which was used in the 
current study [19]. Additionally results from the General fatigue subscale of the PedsQLTM 
Multidimensional Fatigue Scale [20] are reported. Responses were recorded on a 5-point scale 
(ranging from never to almost always) and subsequently linearly transformed to a 0-100 scale 
with higher scores reflecting fewer symptoms of fatigue. 
 
Covariates 
Bober and Varela’s integrative biopsychosocial model of cancer-related sexual problems was 
used to select covariates [3]. The model includes four interacting elements postulated as 
contributors to cancer-related sexual problems: biologic, interpersonal, psychological and 
social/cultural. In the present study, biologic factors were measured by treatment intensity (a 
composite variable derived based on cancer type, stage, and treatment modalities) [11], ongoing 
cancer treatment, time from diagnosis to follow-up, and self-assessed fatigue severity and 
interference. We measured Psychological factors with the global mental component summary 
(MCS) score of the SF-12 [16] and satisfaction with one’s body (i.e., perceived impact of cancer 
on physical appearance).  Social/Cultural factors included race/ethnicity and level of education. 
Interpersonal factors were measured by relationship status and whether the respondent was 
raising children. Additionally, age at diagnosis (15-24 vs. 25-39 years) and gender were included 
in the modelling as covariates since prior research indicates that these are both prominent factors 
in shaping satisfaction with sexual functioning and intimate relationships [21]. 
 
Statistical analysis 
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Sexual function concerns (frequency, proportion endorsing negative impact) were described for 
AYAs one and two years after diagnosis and differences between the two surveys were examined 
with the McNemar-Bowker test. For those concerns that statistically significantly changed 
between the two points of measurement we investigated the number of individuals who persisted 
in reporting a negative impact at second assessment (two years after diagnosis). We conducted 
multivariate logistic regression to examine associations between sexual function, and 
demographic and clinical characteristics as well as selected self-reported health outcomes, and 
dissatisfaction with physical appearance. Covariates (age at diagnosis, gender, race, education, 
partner-committed relationship, raising children, treatment intensity, ongoing cancer treatment, 
time from diagnosis to follow-up, self-reported fatigue, mental health and physical appearance) 
were selected a priori, based on the conceptual model and the literature. All self-reported data 
included in the regression analysis were assessed at two years after diagnosis (i.e. fatigue, mental 
health, physical appearance, education, partner-committed relationship raising children, and 
ongoing cancer treatment). The model was evaluated using a significance level of p<0.05, 
Nagelkerke’s R2 and the percentage of cases correctly classified. 
 
Statistical analyses were performed with the IBM® SPSS® Statistics, version 21.  All tests were 
two-tailed with values of p<.05 considered significant. 
Results 
Data on 465 participants were included in this analysis. Socio-demographic and clinical 
characteristics of participating patients are presented in Table 1. The majority of participants was 
male (62%), non-Hispanic white (60%), raised children under 18 years (59%), and had received 
treatment including chemotherapy (71%) [12]. 
One year after diagnosis 49% of the respondents reported that cancer had a negative impact on 
their sexual function and intimacy, 59% held negative feelings about their physical appearance, 
and 46% negative impact on plans for having children (Table 2). At two years post-diagnosis, the 
proportion reporting a negative impact in specific domains had significantly declined (Sexual 
function, p<.01; Physical appearance, p<.05). However, a negative impact on sexual function 
(43%) and negative feelings of body appearance (50%) remained prevalent. Among those 
reporting a negative impact on sexual function or body appearance one year after diagnosis, 70% 
and 72%, respectively, persisted in their perceptions at two years.  Additionally, some of those 
who did not report any negative impact on sexual function (9%) or on body appearance (7%) at 
one year (no impact/ did not apply/positive impact) did so at two years after diagnosis.  
Factors associated with negative impact on sexual function 
In a multivariable logistic regression analysis, older AYAs, those diagnosed at age 25-39 (OR, 
2.53; 95% CI, 1.44-4.42) and those currently not raising children (OR, 1.81; 95% CI, 1.06-3.08) 
were more likely to report negative impact on sexual function/intimate relations (Table 3). 
Additionally, AYAs who reported fatigue (OR, .987; 95% CI, .975-.998) and negative perception 
of their own physical appearance (OR, 3.08; 95% CI, 1.97-4.81) were more likely to report a 
negative impact on sexual function. Other variables examined were non-significant. 
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Discussion 
In our cohort study, a large proportion of AYAs diagnosed with cancer in the U.S. reported a 
negative impact on their sexual life and intimate relations two years following diagnosis (43%), a 
prevalence that only had decreased slightly from one year following diagnosis. Seventy percent 
of those who reported negative impact at one year persisted in their perceptions two years post-
diagnosis. Our results are somewhat comparable to the few AYA studies involving cancer that 
have been published. A systematic review of sexual functioning among male survivors of 
lymphoma, (mean ages across studies ranged from 31 to 45 years) found that 20-54% 
experienced sexual problems [22]. Among testicular cancer patients, a meta-analysis of empirical 
studies showed that among those assessed prospectively, the extent of reported problems varied 
by dysfunction, from 11% (loss of desire) to 51% (ejaculation disorder) [23]. Among young 
breast cancer patients (22-52 years), research suggests that 16-52% of them report sexual 
problems the first year following diagnosis [6, 24]. The percentage of the general population in 
the U.S. reporting sexual problems was recently investigated using a similar general screening 
item and found to be significant lower (10% and 15% of women and men endorsed sexual 
problems, respectively)  than among the AYAs we studied [25].  
Our results confirm that cancer-related sexual problems include the elements presented in the 
Bober and Valera conceptual model. Indeed, AYAs who were diagnosed between ages 25-39, 
were not raising children, were fatigued or perceived their physical appearance to be impacted by 
the cancer were observed to be more likely to report a negative impact on sexual function and 
intimate relations. These findings underscore the need to routinely assess sexual problems in 
clinical practice and to develop interventions for patients who indicate a negative impact on 
sexual function. According to the model, biological factors may be addressed through medical 
consultations and rehabilitation, and interpersonal problems (relationship issues) may be dealt 
within support groups and couples therapy. Recommendations for how to intervene on 
psychological problems vary according to the specific problem and may include individual 
counselling, cognitive-behavioral therapy and sex therapy. Even though the Bober and Varela’s 
model was useful for understanding sexual problems in the study population, there may be other 
factors relevant for AYAs that are not addressed in the model. One potential issue could be 
having your sexual debut with the cancer experience. Communication in partner relationships 
may also be different in AYAs, who are more likely to have a shorter common history. 
Furthermore, whether the integrative biopsychosocial model’s suggested approaches to overcome 
sexual problems are suitable for the AYA population needs to be further studied and 
recommended to be explored in future studies.  
It is well known that sexual problems often are neglected in clinical care due to patients feeling 
embarrassed to discuss the topic and care providers being likewise uncomfortable and often 
lacking training for such discussions [26, 27]. There is a need to find approaches that are easily 
followed to address sexual issues in clinical settings. One such approach is the PLISSIT model, 
which can be used to determine different levels of intervention for treatment of sexual problems. 
The model consists of four steps (Permission, Limited Information, Specific Suggestions, 
Intensive Therapy) with increasing intervention and interaction to the client, related to each step 
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[28]. Park et al. [29] adapted the PLISSIT model for use in oncology practice including some 
straightforward questions about sexual functions, which has been suggested to be posed to cancer 
survivors at routine visits [8, 29]. Specific interventions addressing sexual issues in the AYA 
cancer population are almost nonexistent, as most programs have been directed toward older 
adults. One exception is a pilot study testing a psychoeducational intervention in a sample of 15-
25 year olds [30]. Results showed positive effects on body image, decreases in anxiety and 
psychological distress, and increased cancer-specific knowledge regarding sexual issues. The 
study, however, had difficulties recruiting patients and only those experiencing significant 
emotional distress chose to participate. The reason for the high non-participation rate was 
explained by the stigma associated with treatment of mental health issues and the authors suggest 
that trained nurses or physician assistants should deliver such an intervention rather than a mental 
health provider [30]. Applying this to our results, systematic assessment of sexual function and 
intimate partner relationships in the delivery of survivorship care of AYAs diagnosed with cancer 
is recommended.  
In our study, the association we observed between fatigue and a negative impact on sexual 
function may indicate that AYAs more troubled by their disease and treatment lacked energy to 
engage in sexual activities [5, 31]. We do not know whether fatigue in female participants was 
related to abrupt menopause induced by the cancer treatment, which could also accentuate sexual 
problems [4]. Furthermore, those who were not raising children were more likely to report sexual 
problems. One possible explanation is that those without children were worried about the risk of 
being infertile due to the cancer treatment, and that this worry interfered with sexual function. 
Another explanation could be that in relationships without children there are greater expectations 
of intimacy and sexual activity. Further study beyond the scope of the AYA HOPE dataset is 
warranted to test these hypotheses. Even with 46% of AYAs reporting a positive impact of cancer 
on their relationship with spouse two years after diagnosis (Table 2), 20% indicated that the 
cancer experience had a negative impact on the relationship with their spouse or partner.  It may 
be difficult for healthcare providers to communicate about sexual issues in the context of cancer 
care [26, 29], and our results emphasize the need to reach out to couples at the time of follow-up 
care to address sexual life expectations following cancer treatment [29].  
 
Those perceiving that disease and treatment had a negative impact on physical appearance were 
three times more likely to report a negative impact on sexual function, an association also 
described in previous reports [5, 31]. The association between sexual function and body image is 
supported by the Bober and Valera model and has been suggested to be stronger in younger aged 
adult women [32]. In a recent study on sexually active heterosexual women, body image concerns 
(evaluative, affective, and behavioral) was shown to predict decrements in young women's sexual 
function, specifically desire and arousal [33]. The study authors concluded that interventions to 
improve body image could have benefits related to sexual experience. The relationship between 
body image and sexual function in AYAs with cancer needs further study to better understand 
interplay between body image and sexual function. 
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Interestingly, clinical variables did not appear to be associated with sexual function among 
AYAs; neither time since diagnosis nor treatment intensity, were significantly associated with a 
negative impact on sexual function and intimate relations. Still, the variable ongoing cancer 
treatment almost reached statistical significance, which suggests that treatment may have 
immediate negative effects on sexual function. The role of diagnosis and treatment has been 
discussed in the literature and it has been suggested that other factors may play a larger role in 
maintaining sexual function following cancer, as our results suggest [3]. Issues suggested to play 
a larger role than clinical factors include general health, personal characteristics and quality of the 
partner relationship. 
We did not find that gender was associated with impact on sexual function. Few studies among 
AYAs have analyzed sexual issues in both genders. However, among the general population, 
women report more problems than men [21, 34,], and results among childhood cancer survivors 
show a similar pattern [35]. Given that almost 40% of the participants in our study had germ cell 
cancers, which present and are treated differently in men (testicular cancer) and women (ovarian 
cancer), the results related to the association between gender and sexual problems should be 
interpreted with caution. The sparse data available on race and ethnicity on sexual function 
outcomes, suggest that race, religion and ethnic background may influence the willingness of 
patients to discuss issues pertaining to sexuality [36]. Further study is warranted.   
Even though mental health was not significantly associated with a negative impact on sexual 
function, mental health together with fatigue and physical health should be closely monitored in 
survivorship care, and rehabilitation recommended for those in need (e.g., persistent fatigue) [37]. 
Those reporting potential problems can be recommended for supportive group counselling and 
couples therapy, and if needed individual counselling, or possibly sex therapy. Given the high 
proportion of patients indicating sexual problems, providing educational materials can be helpful 
and particularly appropriate for patients who may be reticent to discuss their sexual problems.  
 
Several caveats should be considered in interpreting our study results. First, though comparable to 
other studies of children and young adults with cancer, our response rate was low. Additionally, 
we were not able to evaluate an extensive array of issues related to sexual function or 
dysfunction. The AYA HOPE study was designed to be a feasibility study to determine whether 
we could gather data from AYA cancer patients using population-based registries. The survey 
goals were to identify indicators of problems in health care and outcomes that require more in-
depth study. Therefore, we only had a single item to assess sexual function. Interestingly, Flynn 
et al. recently validated a single-item self-report screener to capture sexual problems and 
concerns for men and women in the U.S. [25]. They compared results from three possible single-
items, with scores on the comprehensive Patient-Reported Outcomes Measurement Information 
System Sexual Function and Satisfaction measures (PROMIS SexFS) and found promising 
results. They argue that even without being able to identify particular sexual problems, a general 
screener only asking for “any sexual problems” identifies patients who may benefit from further 
discussion with a health care provider. We still recommend future studies to include a more 
comprehensive measure to be able to identify specific sexual problems in AYAs [38]. The 
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measure we used to record mental health, the MCS of the SF-12, was developed for adults and 
has therefore not been validated in study subjects under age 18, however, only few AYAs were 
that young at one year (n=23) and two years (n=11) post-diagnosis and we did not observe 
difficulties with the items when pilot testing the survey.  Strengths of this study include that our 
results are based on a large population-based sample of AYAs with five different cancer types, 
including men and women, and surveyed twice over the two first years after diagnosis. 
Conclusions 
In our study, a large proportion of AYAs diagnosed with cancer in the U.S. reported a negative 
impact on their sexual life and intimate relations extending through the first two years following 
diagnosis. We also identified predictors of AYAs who were more likely to report a negative 
impact on sexual function and intimate relations.  This subgroup was older, not raising children, 
fatigued, and perceived their physical appearance to be negatively impacted by treatment.  Our 
findings underscore the need to incorporate periodic systematic assessment of sexual function and 
intimate partner relationships in the delivery of survivorship care of AYAs following a diagnosis 
of cancer.   
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Table 1. Socio-demographic and clinical characteristics of AYA HOPE sample (N=465) 
                                                                                                                             n    (%) 
Socio-demographic variables 
Gender 
   Female 
   Male 
Age at diagnosis, years* 
    15-19 
    20-24 
    25-29 
    30-34 
    35-39 
Race/Ethnicity* 
    Hispanic 
    White, non- Hispanic 
    Black, non- Hispanic 
    Other, non-Hispanic 
Marital/Relationship status* 
    Single/Never married 
    Married/Living as married 
    Divorced/Separated 
Raising children under 18 years* 
    No 
    Yes 
Level of completed education* 
    High school or less 
    Some college 
    College graduate or higher 
Disease-related variables 
Time from diagnosis to follow-up, median months (range) 
Cancer type (baseline) 
    Germ cell cancer 
    Hodgkin lymphoma 
    Non-Hodgkin lymphoma 
    Sarcoma 
    Acute lymphocytic leukemia 
Treatment type 
    Surgery only 
    Radiation 
    Chemotherapy  
    Combined modality chemoradiotherapy 
    Unknown/NA 
Treatment intensity 
    Least intensive 
    Moderately intensive 
    Very intensive 
    NA / No MR  
Ongoing cancer treatment at follow-up* 
 
 
178 (38.3) 
287 (61.7) 
 
 62 (13.3)  
 81 (17.4) 
 98 (21.1) 
104 (22.4) 
104 (22.4) 
 
 95 (20.4) 
277 (59.6) 
 38 (8.2) 
 54 (11.6) 
 
228 (49.0) 
214 (46.0) 
 22 (4.7) 
 
189 (40.7) 
275 (59.3) 
 
107 (23.0) 
179 (38.5) 
174 (37.4) 
 
 24 (15-35) 
   
181 (38.9) 
130 (28.0) 
113 (24.3) 
23 (4.9) 
18 (3.9) 
 
50 (10.8) 
48 (10.3) 
225 (48.4) 
107 (23.0) 
35 (7.5) 
 
47 (10.1) 
261 (56.1) 
128 (27.5) 
29 (6.2) 
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    No or unknown 
        Yes 
Self-reported Health 
PEDsQL Fatigue, mean (SD) 
Mental Health component summary (MCS), mean (SD) 
400 (86.0) 
49 (10.5) 
 
62.76 (24.51) 
46.01 (11.18) 
*Does not sum to total due to missing data 
NA, Not applicable; No MR, No medical records 
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  Table 2. Sexual function and related concerns over two years following 
diagnosis of cancer for all participants responding at both occasions (N=465) 
 
 1 year after diagnosis 
Survey I n=465 (%) 
2 years after diagnosis 
Survey II n= 465 (%) 
 
X2 
 
     Pa 
Impact on sexual function/intimate relations*   29.66 .009 
 Very or somewhat negative  227 (48.8) 202 (43.4)  
 No impact 149 (32.0) 167 (35.9)  
 Somewhat or very positive 20 (4.3) 38 (8.2)  
 Does not apply 63 (13.5) 57 (12.3)  
Feelings about physical appearance*   27.34 .026 
 Very or somewhat negative  275 (59.1) 234 (50.3) 
 No impact 132 (28.4) 147 (31.6) 
 Somewhat or very positive 45 (9.7) 64 (13.8) 
 Does not apply 8 (1.7) 16 (3.4) 
Overall impact of cancer on dating*   24.0 .900 
 Very or somewhat negative  83 (17.8) 86 (18.5) 
 No impact 93 (20.0) 109 (23.4) 
 Somewhat or very positive 18 (3.9) 26 (5.6) 
 Does not apply 264 (56.8) 240 (51.6) 
Impact on relationship with spouse/partner*   24.0 .090 
 Very or somewhat negative  73 (15.7) 90 (19.4) 
 No impact 53 (11.4) 73 (15.7) 
 Somewhat or very positive  232 (49.9) 214 (46.0) 
 Does not apply 98 (21.1) 83 (17.8) 
Impact on plans for having children*   22.05 .107 
 Very or somewhat negative  213 (45.8) 197 (42.4)   
 No impact  
 Somewhat or very positive 
116 (24.9) 
20 (4.3) 
112 (24.1) 
40 (8.6) 
  
 Does not apply 111 (23.9) 115 (24.7) 
aMcNemar-Bowker test 
*Does not sum to total due to missing data 
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Table 3. Factors predictive of negative effects of cancer treatment on sexual function/intimate relations 
at two years post-diagnosis (n=449*) 
   
 
 
Adjusted 
OR** 
 
95% CI  
Age at diagnosis, years 
  15-24 
  25-39  
Sex 
  Male  
  Female  
  
 
 
 
Ref 
2.526 
 
Ref 
1.208 
 
 
1.443-4.419 
 
 
.761-1.917 
Race 
  Hispanic  
  Non-white, non-Hispanic 
  White  
  
 
 
 
Ref 
.619 
1.263 
 
 
.303-1.261 
.726-2.196 
Committed relationship 
  No  
  Yes 
   
Ref 
1.643 
 
 
.969-2.788 
Education 
  High school or less 
  Some college 
  College graduate 
   
Ref 
1.480 
1.241 
 
 
.832-2.634 
.668-2.309 
Raising children  
  Raising children <18 years 
  Not raising children <18 years 
  
 
 
 
Ref 
1.806 
 
 
1.058-3.083 
Treatment intensity 
  Less intense treatment 
  Moderately intensive 
  Intense treatment 
  
 
 
Ref 
1.004 
.686 
 
 
.479-2.103 
.300-1.581 
Ongoing cancer treatment 
  No/unknown 
  Yes 
   
Ref 
.489 
 
 
.238-1.004 
Time since diagnosis (months)   .987 .936-1.041 
Mental health component summary (MCS) scorea  .985 .961-1.010 
PEDsQL Fatigue scorea   .987 .975-998 
Physical appearance 
  No negative impact 
  Negative impact 
  
 
 
 
Ref 
3.077 
 
 
1.968-4.810 
Model summary Χ296.812 p<.0005, Nagelkerke R2=.260; 70.2% classified 
*Difference in sample size due to missing item responses for 16 participants 
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**Odds ratios are adjusted for all other variables in the table 
aMCS and PEDsQL are treated as continuous variables in the model  
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